Kim, Jin Won http://orcid.org/0000-0002-1357-7015
Lee, Kyung-Hun
Kim, Ji-Won
Suh, Koung Jin
Nam, Ah-Rong
Bang, Ju-Hee
Bang, Yung-Jue
Oh, Do-Youn
Funding for this research was provided by:
Seoul National University Hospital (03-2017-0100)
Article History
Received: 26 March 2019
Revised: 11 June 2019
Accepted: 24 June 2019
First Online: 17 July 2019
Competing interests
: The authors declare no competing interests.
: All participating patients provided a written informed consent. This study was approved by the institutional review boards of each hospital (Seoul National University Hospital: H-1407-152-597, Seoul National University Bundang Hospital: B-1610/365-405). The study was performed in accordance with the Declaration of Helsinki.
: This study was partly funded by Array BioPharma, and by grant No. 03-2017-0100 from the Seoul National University Hospital Research Fund. Capecitabine was kindly provided by Ildong Pharmaceutical Co., Seoul, Korea.
: Not applicable.
: All data and materials are available by inquiring to the corresponding author.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).